Sun Pharmaceutical Industries Limited (SUNPHARMA) — Announcement Announcement
📢 Key Event
Sun Pharma schedules June 2026 investor meetings with BofA, Morgan Stanley, and Citi
💡 Investor Takeaway
Investors can engage directly with management but should not expect new price-sensitive information.
Sun Pharmaceutical announced its upcoming analyst and institutional investor meeting schedule for June 2026, listing three physical events with BofA, Morgan Stanley, and Citi. The company emphasized no UPSI will be disclosed during these sessions, and the schedule remains subject to change. These meetings provide investors direct access to management without new financial disclosures.
📄 View Original Announcement (PDF)
About Sun Pharmaceutical Industries Limited (SUNPHARMA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹4,50,643.09 Cr
P/E: 41.3
ROE: 15.1%
ROCE: 20.3%
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.